Library Subscription: Guest
Critical Reviews™ in Neurobiology

Published 3 issues per year

ISSN Print: 0892-0915

ISSN Online: 2375-0014

SJR: 0.121

Regulation of Cannabinoid CB1 Receptors in the Central Nervous System by Chronic Cannabinoids

Volume 15, Issue 2, 2003, 30 pages
DOI: 10.1615/CritRevNeurobiol.v15.i2.10
Get accessGet access

ABSTRACT

Marijuana produces a number of characteristic behaviors in humans and animals, including memory impairment, antinociception, and locomotor and psychoactive effects. However, tolerance and dependence to cannabinoids develops after chronic use, as demonstrated both clinically and in animal models. The potential therapeutic benefits of certain cannabinoid-mediated effects, as well as the use of marijuana for its psychoactive properties, has raised interest in understanding the cellular adaptations produced by chronic administration of this class of drugs. The primary active constituent of marijuana, delta9-tetrahydrohydrocannabinol (THC), binds to specific G-protein-coupled receptors. The central nervous system (CNS) effects of THC are mediated by CB1 receptors, which couple primarily to inhibitory G-proteins. High levels of CB1 receptors are found in the basal ganglia, hippocampus, cortex, and cerebellum, consistent with the profile of behavioral effects. Studies over the past decade have determined that CB1 receptors undergo downregulation and desensitization following chronic administration of THC or synthetic cannabinoid agonists. In general, these adaptations are regionally widespread and of considerable magnitude, and are thought to contribute to tolerance to cannabinoid- mediated behavioral effects. Adaptation at the effector level has been more difficult to characterize, although it appears that alterations in cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) activity may be particularly important in cannabinoid dependence. A striking characteristic of CB1 receptor adaptation is the region dependence of the magnitude and rate of development of downregulation and desensitization. These regional differences may provide interesting insights into the mechanisms of CB1 receptors receptor signaling in different brain regions. Moreover, region-specific adaptations in CB1 receptors following chronic cannabinoid administration may produce differential adaptations at the in vivo level.

CITED BY
  1. Barna István, Soproni Krisztina, Arszovszki Antónia, Csabai Katalin, Haller József, WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids, Behavioural Pharmacology, 18, 5-6, 2007. Crossref

  2. Martini Lene, Thompson Dawn, Kharazia Viktor, Whistler Jennifer L, Differential Regulation of Behavioral Tolerance to WIN55,212-2 by GASP1, Neuropsychopharmacology, 35, 6, 2010. Crossref

  3. Pertwee Roger G, Cannabinoid pharmacology: the first 66 years, British Journal of Pharmacology, 147, S1, 2006. Crossref

  4. Dalton Victoria S., Wang Hongqin, Zavitsanou Katerina, HU210-Induced Downregulation in Cannabinoid CB1 Receptor Binding Strongly Correlates with Body Weight Loss in the Adult Rat, Neurochemical Research, 34, 7, 2009. Crossref

  5. Moranta David, Esteban Susana, García-Sevilla Jesús A., Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain, Naunyn-Schmiedeberg's Archives of Pharmacology, 379, 1, 2009. Crossref

  6. Moranta David, Esteban Susana, García-Sevilla Jesús A., Acute, chronic and withdrawal effects of the cannabinoid receptor agonist WIN55212-2 on the sequential activation of MAPK/Raf-MEK-ERK signaling in the rat cerebral frontal cortex: Short-term regulation by intrinsic and extrinsic pathways, Journal of Neuroscience Research, 85, 3, 2007. Crossref

  7. Battisti Robert A., Roodenrys Steven, Johnstone Stuart J., Respondek Colleen, Hermens Daniel F., Solowij Nadia, Chronic use of cannabis and poor neural efficiency in verbal memory ability, Psychopharmacology, 209, 4, 2010. Crossref

  8. van Winkel Ruud, Henquet Cécile, Rosa Araceli, Papiol Sergi, Faňanás Lourdes, De Hert Marc, Peuskens Jozef, van Os Jim, Myin-Germeys Inez, Evidence that the COMTVal158Met polymorphism moderates sensitivity to stress in psychosis: An experience-sampling study, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B, 1, 2008. Crossref

  9. Dalton Victoria S., Zavitsanou Katerina, Cannabinoid effects on CB1 receptor density in the adolescent brain: An autoradiographic study using the synthetic cannabinoid HU210, Synapse, 64, 11, 2010. Crossref

  10. Pertwee Roger G., The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids, The AAPS Journal, 7, 3, 2005. Crossref

  11. Fan Ni, Yang Hongwei, Zhang Jian, Chen Chu, Reduced expression of glutamate receptors and phosphorylation of CREB are responsible forin vivoΔ9-THC exposure-impaired hippocampal synaptic plasticity, Journal of Neurochemistry, 112, 3, 2010. Crossref

  12. Pertwee R G, The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin, British Journal of Pharmacology, 153, 2, 2008. Crossref

  13. Hasan Alkomiet, Rothenberger Aribert, Münchau Alexander, Wobrock Thomas, Falkai Peter, Roessner Veit, Oral Δ9-Tetrahydrocannabinol Improved Refractory Gilles de la Tourette Syndrome in an Adolescent by Increasing Intracortical Inhibition, Journal of Clinical Psychopharmacology, 30, 2, 2010. Crossref

  14. Morel Lydie J, Giros Bruno, Daugé Valérie, Adolescent Exposure to Chronic Delta-9-Tetrahydrocannabinol Blocks Opiate Dependence in Maternally Deprived Rats, Neuropsychopharmacology, 34, 11, 2009. Crossref

  15. Burston James J, Wiley Jenny L, Craig Abimbola A, Selley Dana E, Sim-Selley Laura J, Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Δ9-tetrahydrocannabinol exposure, British Journal of Pharmacology, 161, 1, 2010. Crossref

  16. Falenski Katherine W, Thorpe Andrew J, Schlosburg Joel E, Cravatt Benjamin F, Abdullah Rehab A, Smith Tricia H, Selley Dana E, Lichtman Aron H, Sim-Selley Laura J, FAAH−/− Mice Display Differential Tolerance, Dependence, and Cannabinoid Receptor Adaptation After Δ9-Tetrahydrocannabinol and Anandamide Administration, Neuropsychopharmacology, 35, 8, 2010. Crossref

  17. Álvaro-Bartolomé M, Esteban S, García-Gutiérrez MS, Manzanares J, Valverde O, García-Sevilla JA, Regulation of Fas receptor/Fas-asssociated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain, British Journal of Pharmacology, 160, 3, 2010. Crossref

  18. Henquet Cécile, Rosa Araceli, Krabbendam Lydia, Papiol Sergi, Faňanás Lourdes, Drukker Marjan, Ramaekers Johannes G, van Os Jim, An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of Δ-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition, Neuropsychopharmacology, 31, 12, 2006. Crossref

  19. Smith Tricia H, Sim-Selley Laura J, Selley Dana E, Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?, British Journal of Pharmacology, 160, 3, 2010. Crossref

  20. Sundram Suresh, Copolov David, Dean Brian, Clozapine decreases [3H] CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens, Naunyn-Schmiedeberg's Archives of Pharmacology, 371, 5, 2005. Crossref

  21. Pertwee R G, The pharmacology of cannabinoid receptors and their ligands: an overview, International Journal of Obesity, 30, S1, 2006. Crossref

  22. Mato Susana, Aso Ester, Castro Elena, Martín Miquel, Valverde Olga, Maldonado Rafael, Pazos Ángel, CB1knockout mice display impaired functionality of 5-HT1Aand 5-HT2A/Creceptors, Journal of Neurochemistry, 103, 5, 2007. Crossref

  23. Haller J., Szirmai M., Varga B., Ledent C., Freund T. F., Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia, Behavioural Pharmacology, 16, 5-6, 2005. Crossref

  24. Childers Steven R., Activation of G-proteins in brain by endogenous and exogenous cannabinoids, The AAPS Journal, 8, 1, 2006. Crossref

  25. Dowie M.J., Howard M.L., Nicholson L.F.B., Faull R.L.M., Hannan A.J., Glass M., Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice, Neuroscience, 170, 1, 2010. Crossref

  26. Nallapaneni Anuradha, Liu Jing, Karanth Subramanya, Pope Carey, Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2, Toxicology, 227, 1-2, 2006. Crossref

  27. Daigle Tanya L., Kearn Christopher S., Mackie Ken, Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling, Neuropharmacology, 54, 1, 2008. Crossref

  28. Nguyen P.T., Selley D.E., Sim-Selley L.J., Statistical Parametric Mapping reveals ligand and region-specific activation of G-proteins by CB1 receptors and non-CB1 sites in the 3D reconstructed mouse brain, NeuroImage, 52, 4, 2010. Crossref

  29. Hoot Michelle R., Sim-Selley Laura J., Poklis Justin L., Abdullah Rehab A., Scoggins Krista L., Selley Dana E., Dewey William L., Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice, Brain Research, 1339, 2010. Crossref

  30. Harte Lauren C., Dow-Edwards Diana, Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannabinol exposure in the rat, Neurotoxicology and Teratology, 32, 5, 2010. Crossref

  31. Wagner Daniel, Becker Benjamin, Gouzoulis-Mayfrank Euphrosyne, Daumann Jörg, Interactions between specific parameters of cannabis use and verbal memory, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34, 6, 2010. Crossref

  32. Llorente-Berzal Alvaro, Fuentes Sílvia, Gagliano Humberto, López-Gallardo Meritxell, Armario Antonio, Viveros María-Paz, Nadal Roser, Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour, Addiction Biology, 16, 4, 2011. Crossref

  33. Bui Cuong J., McGann Alexandra C., Middleton Frank A., Beaman-Hall Carol M., Vallano Mary Lou, Transcriptional profiling of depolarization-dependent phenotypic alterations in primary cultures of developing granule neurons, Brain Research, 1119, 1, 2006. Crossref

  34. Wiley Jenny L., Jones Amanda R., Wright M. Jerry, Exposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced motor effects in female rats, Neuropharmacology, 60, 2-3, 2011. Crossref

  35. Smith Paul A., Selley Dana E., Sim-Selley Laura J., Welch Sandra P., Low dose combination of morphine and Δ9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors, European Journal of Pharmacology, 571, 2-3, 2007. Crossref

  36. Pelayo-Terán José María, Pérez-Iglesias Rocío, Mata Ignacio, Carrasco-Marín Eugenio, Vázquez-Barquero José Luis, Crespo-Facorro Benedicto, Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: Clinical-onset implications, Psychiatry Research, 179, 3, 2010. Crossref

  37. van Hell Hendrika H., Vink Matthijs, Ossewaarde Lindsey, Jager Gerry, Kahn René S., Ramsey Nick F., Chronic effects of cannabis use on the human reward system: An fMRI study, European Neuropsychopharmacology, 20, 3, 2010. Crossref

  38. Howlett Allyn C., Breivogel Christopher S., Childers Steven R., Deadwyler Samuel A., Hampson Robert E., Porrino Linda J., Cannabinoid physiology and pharmacology: 30 years of progress, Neuropharmacology, 47, 2004. Crossref

  39. Rodriguez Jesse S., Boctor Sherin Y., Flores Luke C., Phelix Clyde F., Martinez Joe L., Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration, Neuroscience Letters, 489, 3, 2011. Crossref

  40. Martin Billy R, Sim-Selley Laura J, Selley Dana E, Signaling pathways involved in the development of cannabinoid tolerance, Trends in Pharmacological Sciences, 25, 6, 2004. Crossref

  41. Lundberg Daniel J., Daniel Andrea R., Thayer Stanley A., Δ9-Tetrahydrocannabinol-induced desensitization of cannabinoid-mediated inhibition of synaptic transmission between hippocampal neurons in culture, Neuropharmacology, 49, 8, 2005. Crossref

  42. Esteban Susana, García-Sevilla Jesús A., Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 38, 1, 2012. Crossref

  43. Vallano Mary Lou, Beaman-Hall Carol M., Bui Cuong J., Middleton Frank A., Depolarization and Ca2+ downregulate CB1 receptors and CB1-mediated signaling in cerebellar granule neurons, Neuropharmacology, 50, 6, 2006. Crossref

  44. Hu H., Ho W., Mackie K., Pittman Q.J., Sharkey K.A., Brain CB1 receptor expression following lipopolysaccharide-induced inflammation, Neuroscience, 227, 2012. Crossref

  45. Thibault Karine, Carrel Damien, Bonnard Damien, Gallatz Katalin, Simon Anne, Biard Marc, Pezet Sophie, Palkovits Miklos, Lenkei Zsolt, Activation-Dependent Subcellular Distribution Patterns of CB1 Cannabinoid Receptors in the Rat Forebrain, Cerebral Cortex, 23, 11, 2013. Crossref

  46. Pertwee Roger G., Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond, Addiction Biology, 13, 2, 2008. Crossref

  47. Marijuana (Cannabis sativaL.) and Synthetic Cannabinoids, in Medical Toxicology of Drug Abuse, 2012. Crossref

  48. Sayers Katherine W., Nguyen Peter T., Blair Robert E., Sim-Selley Laura J., DeLorenzo Robert J., Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain, Epilepsia, 53, 5, 2012. Crossref

  49. Simonetto Douglas A., Oxentenko Amy S., Herman Margot L., Szostek Jason H., Cannabinoid Hyperemesis: A Case Series of 98 Patients, Mayo Clinic Proceedings, 87, 2, 2012. Crossref

  50. Ginovart Nathalie, Tournier Benjamin B, Moulin-Sallanon Marcelle, Steimer Thierry, Ibanez Vicente, Millet Philippe, Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems, Neuropsychopharmacology, 37, 11, 2012. Crossref

  51. Steinmetz Adam B., Edwards Chad R., Vollmer Jennifer M., Erickson Molly A., O’Donnell Brian F., Hetrick William P., Skosnik Patrick D., Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans, Psychopharmacology, 221, 1, 2012. Crossref

  52. Nguyen Vu H., Verdurand Mathieu, Dedeurwaerdere Stefanie, Wang Hongqin, Zahra David, Gregoire Marie-Claude, Zavitsanou Katerina, Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: A small animal PET imaging study with 18F-FDG, Brain Research Bulletin, 87, 2-3, 2012. Crossref

  53. Nguyen Peter T., Schmid Cullen L., Raehal Kirsten M., Selley Dana E., Bohn Laura M., Sim-Selley Laura J., β-Arrestin2 Regulates Cannabinoid CB1 Receptor Signaling and Adaptation in a Central Nervous System Region–Dependent Manner, Biological Psychiatry, 71, 8, 2012. Crossref

  54. Montgomery C., Seddon A. L., Fisk J. E., Murphy P. N., Jansari A., Cannabis-related deficits in real-world memory, Human Psychopharmacology: Clinical and Experimental, 27, 2, 2012. Crossref

  55. Gofeld M., Robinson S., Faclier G., Administration of nabilone for postoperative pain control in the marijuana-addicted: Case study, Acute Pain, 8, 1, 2006. Crossref

  56. Roser Patrik, Lissek Silke, Tegenthoff Martin, Nicolas Volkmar, Juckel Georg, Brüne Martin, Alterations of theory of mind network activation in chronic cannabis users, Schizophrenia Research, 139, 1-3, 2012. Crossref

  57. Kleyer Jonas, Nicolussi Simon, Taylor Peter, Simonelli Deborah, Furger Evelyne, Anderle Pascale, Gertsch Jürg, Cannabinoid receptor trafficking in peripheral cells is dynamically regulated by a binary biochemical switch, Biochemical Pharmacology, 83, 10, 2012. Crossref

  58. van Hell Hendrika H., Vink Matthijs, Ossewaarde Lindsey, Jager Gerry, Kahn René S., Ramsey Nick F., Efectos crónicos del consumo de cannabis sobre el sistema de recompensa humano: un estudio de RMf, Psiquiatría Biológica, 18, 2, 2011. Crossref

  59. Lazenka M.F., Selley D.E., Sim-Selley L.J., Brain regional differences in CB1 receptor adaptation and regulation of transcription, Life Sciences, 92, 8-9, 2013. Crossref

  60. Grimsey Natasha L., Graham E. Scott, Dragunow Mike, Glass Michelle, Cannabinoid Receptor 1 trafficking and the role of the intracellular pool: Implications for therapeutics, Biochemical Pharmacology, 80, 7, 2010. Crossref

  61. Jefferson Delroy A., Harding Hyacinth E., Cawich Shamir O., Jackson-Gibson Anne, Postoperative Analgesia in the Jamaican Cannabis User, Journal of Psychoactive Drugs, 45, 3, 2013. Crossref

  62. Ceccarini Jenny, Kuepper Rebecca, Kemels Dieter, van Os Jim, Henquet Cécile, Van Laere Koen, [18F]MK-9470 PET measurement of cannabinoid CB1receptor availability in chronic cannabis users, Addiction Biology, 20, 2, 2015. Crossref

  63. Burston James J., Woodhams Stephen G., Endocannabinoid system and pain: an introduction, Proceedings of the Nutrition Society, 73, 1, 2014. Crossref

  64. Li Lin, Sase Ajinkya, Patil Sudarshan, Sunyer Berta, Höger Harald, Smalla Karl-Heinz, Stork Oliver, Lubec Gert, Distinct set of kinases induced after retrieval of spatial memory discriminate memory modulation processes in the mouse hippocampus, Hippocampus, 23, 8, 2013. Crossref

  65. Puighermanal Emma, Busquets-Garcia Arnau, Gomis-González Maria, Marsicano Giovanni, Maldonado Rafael, Ozaita Andrés, Dissociation of the Pharmacological Effects of THC by mTOR Blockade, Neuropsychopharmacology, 38, 7, 2013. Crossref

  66. Cutando Laura, Busquets-Garcia Arnau, Puighermanal Emma, Gomis-González Maria, Delgado-García José María, Gruart Agnès, Maldonado Rafael, Ozaita Andrés, Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure, Journal of Clinical Investigation, 123, 7, 2013. Crossref

  67. Álvaro-Bartolomé M., García-Sevilla J.A., Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents, Neuroscience, 247, 2013. Crossref

  68. Selley Dana E., Welch Sandra P., Sim-Selley Laura J., Sphingosine lysolipids in the CNS: Endogenous cannabinoid antagonists or a parallel pain modulatory system?, Life Sciences, 93, 5-6, 2013. Crossref

  69. Lazenka Matthew F., Selley Dana E., Sim-Selley Laura J., ΔFosB induction correlates inversely with CB1 receptor desensitization in a brain region-dependent manner following repeated Δ9-THC administration, Neuropharmacology, 77, 2014. Crossref

  70. Le Foll Bernard, Trigo Jose M., Sharkey Keith A., Strat Yann Le, Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss?, Medical Hypotheses, 80, 5, 2013. Crossref

  71. Skosnik Patrick D, Krishnan Giri P, D'Souza Deepak C, Hetrick William P, O'Donnell Brian F, Disrupted Gamma-Band Neural Oscillations During Coherent Motion Perception in Heavy Cannabis Users, Neuropsychopharmacology, 39, 13, 2014. Crossref

  72. Bick Benjamin L., Szostek Jason H., Mangan Thomas F., Synthetic Cannabinoid Leading to Cannabinoid Hyperemesis Syndrome, Mayo Clinic Proceedings, 89, 8, 2014. Crossref

  73. Lazenka Matthew F., David Bethany G., Lichtman Aron H., Nestler Eric J., Selley Dana E., Sim-Selley Laura J., Delta FosB and AP-1-mediated transcription modulate cannabinoid CB1 receptor signaling and desensitization in striatal and limbic brain regions, Biochemical Pharmacology, 91, 3, 2014. Crossref

  74. Alger Bradley E., Seizing an Opportunity for the Endocannabinoid System, Epilepsy Currents, 14, 5, 2014. Crossref

  75. Fanarioti Eleni, Mavrikaki Maria, Panagis George, Mitsacos Ada, Nomikos George G., Giompres Panagiotis, Behavioral and Neurochemical Changes in Mesostriatal Dopaminergic Regions of the Rat after Chronic Administration of the Cannabinoid Receptor Agonist WIN55,212-2, International Journal of Neuropsychopharmacology, 18, 6, 2015. Crossref

  76. Wetherill Reagan R., Jagannathan Kanchana, Hager Nathan, Childress Anna Rose, Rao Hengyi, Franklin Teresa R., Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume, International Journal of Neuropsychopharmacology, 18, 10, 2015. Crossref

  77. D’Souza Deepak Cyril, Cortes-Briones Jose A., Ranganathan Mohini, Thurnauer Halle, Creatura Gina, Surti Toral, Planeta Beata, Neumeister Alexander, Pittman Brian, Normandin Marc D., Kapinos Michael, Ropchan Jim, Huang Yiyun, Carson Richard E., Skosnik Patrick D., Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 1, 1, 2016. Crossref

  78. Renard Justine, Vitalis Tania, Rame Marion, Krebs Marie-Odile, Lenkei Zsolt, Le Pen Gwenaëlle, Jay Thérèse M., Chronic cannabinoid exposure during adolescence leads to long-term structural and functional changes in the prefrontal cortex, European Neuropsychopharmacology, 26, 1, 2016. Crossref

  79. Molina Patricia E., Amedee Angela M., Winsauer Peter, Nelson Steve, Bagby Gregory, Simon Liz, Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model, Journal of Neuroimmune Pharmacology, 10, 2, 2015. Crossref

  80. Davies John A., Substance Abuse Agents, in xPharm: The Comprehensive Pharmacology Reference, 2007. Crossref

  81. Zobor Ditta, Strasser Torsten, Zobor Gergely, Schober Franziska, Messias Andre, Strauss Olaf, Batra Anil, Zrenner Eberhart, Ophthalmological assessment of cannabis-induced persisting perception disorder: Is there a direct retinal effect?, Documenta Ophthalmologica, 130, 2, 2015. Crossref

  82. Tai S., Hyatt W.S., Gu C., Franks L.N., Vasiljevik T., Brents L.K., Prather P.L., Fantegrossi W.E., Repeated administration of phytocannabinoid Δ9-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner, Pharmacological Research, 102, 2015. Crossref

  83. Blair Robert E., Deshpande Laxmikant S., DeLorenzo Robert J., Endocannabinoids and epilepsy, in Cannabinoids in Neurologic and Mental Disease, 2015. Crossref

  84. Silva Lindsay, Harte-Hargrove Lauren, Izenwasser Sari, Frank Ashley, Wade Dean, Dow-Edwards Diana, Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat, Neuroscience Letters, 602, 2015. Crossref

  85. Rosenberg Evan C., Tsien Richard W., Whalley Benjamin J., Devinsky Orrin, Cannabinoids and Epilepsy, Neurotherapeutics, 12, 4, 2015. Crossref

  86. Hiebel Christof, Behl Christian, The complex modulation of lysosomal degradation pathways by cannabinoid receptors 1 and 2, Life Sciences, 138, 2015. Crossref

  87. Lorenzetti Valentina, Solowij Nadia, Yücel Murat, The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users, Biological Psychiatry, 79, 7, 2016. Crossref

  88. Bosker Wendy M., Karschner Erin L., Lee Dayong, Goodwin Robert S., Hirvonen Jussi, Innis Robert B., Theunissen Eef L., Kuypers Kim P. C., Huestis Marilyn A., Ramaekers Johannes G., Taffe Michael, Psychomotor Function in Chronic Daily Cannabis Smokers during Sustained Abstinence, PLoS ONE, 8, 1, 2013. Crossref

  89. Sorensen Cecilia J., DeSanto Kristen, Borgelt Laura, Phillips Kristina T., Monte Andrew A., Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review, Journal of Medical Toxicology, 13, 1, 2017. Crossref

  90. Brumback T., Castro N., Jacobus J., Tapert S., Effects of Marijuana Use on Brain Structure and Function, in Imaging the Addicted Brain, 129, 2016. Crossref

  91. Zanotti-Fregonara Paolo, Hirvonen Jussi, Lyoo Chul Hyoung, Zoghbi Sami S., Rallis-Frutos Denise, Huestis Marilyn A., Morse Cheryl, Pike Victor W., Innis Robert B., Catapano Alberico, Population-Based Input Function Modeling for [18F]FMPEP-d2, an Inverse Agonist Radioligand for Cannabinoid CB1 Receptors: Validation in Clinical Studies, PLoS ONE, 8, 4, 2013. Crossref

  92. Ganzer Florian, Bröning Sonja, Kraft Stefanie, Sack Peter-Michael, Thomasius Rainer, Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults, Neuropsychology Review, 26, 2, 2016. Crossref

  93. Zhang Houzhong, Li Li, Sun Yanli, Zhang Xingyi, Zhang Yifan, Xu Shuang, Zhao Peng, Liu Tiecheng, Sevoflurane prevents stroke-induced depressive and anxiety behaviors by promoting cannabinoid receptor subtype I-dependent interaction between β-arrestin 2 and extracellular signal-regulated kinases 1/2 in the rat hippocampus, Journal of Neurochemistry, 137, 4, 2016. Crossref

  94. Liu Xiaojie, Chen Yao, Vickstrom Casey R., Li Yan, Viader Andreu, Cravatt Benjamin F., Liu Qing-song, Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase, Scientific Reports, 6, 1, 2016. Crossref

  95. Curran H. Valerie, Freeman Tom P., Mokrysz Claire, Lewis David A., Morgan Celia J. A., Parsons Loren H., Keep off the grass? Cannabis, cognition and addiction, Nature Reviews Neuroscience, 17, 5, 2016. Crossref

  96. Tournier Benjamin B., Tsartsalis Stergios, Dimiziani Andrea, Millet Philippe, Ginovart Nathalie, Time-dependent effects of repeated THC treatment on dopamine D2/3 receptor-mediated signalling in midbrain and striatum, Behavioural Brain Research, 311, 2016. Crossref

  97. Goodman Michelle S., Bridgman Alanna C., Rabin Rachel A., Blumberger Daniel M., Rajji Tarek K., Daskalakis Zafiris J., George Tony P., Barr Mera S., Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls, Brain Stimulation, 10, 2, 2017. Crossref

  98. Faure Céline, Schwitzer Thomas, Hansen Céline, Randhawa Sandeep, Diagnostic and Therapeutic Challenges, Retina, 36, 12, 2016. Crossref

  99. Breivogel Chris S., Sim-Selley Laura J., Basic neuroanatomy and neuropharmacology of cannabinoids, International Review of Psychiatry, 21, 2, 2009. Crossref

  100. Feliszek Monika, Bindila Laura, Lutz Beat, Zimmer Andreas, Bilkei-Gorzo Andras, Schlicker Eberhard, Lack of hippocampal CB1 receptor desensitization by Δ9-tetrahydrocannabinol in aged mice and by low doses of JZL 184, Naunyn-Schmiedeberg's Archives of Pharmacology, 389, 6, 2016. Crossref

  101. Wright Natasha E., Scerpella Danny, Lisdahl Krista M., Hashimoto Kenji, Marijuana Use Is Associated with Behavioral Approach and Depressive Symptoms in Adolescents and Emerging Adults, PLOS ONE, 11, 11, 2016. Crossref

  102. Fluharty Meg E., Heron Jon, Munafò Marcus R., Longitudinal associations of social cognition and substance use in childhood and early adolescence: findings from the Avon Longitudinal Study of Parents and Children, European Child & Adolescent Psychiatry, 27, 6, 2018. Crossref

  103. Ketcherside Ariel, Noble Lindsey J., McIntyre Christa K., Filbey Francesca M., Cannabinoid Receptor 1 Gene by Cannabis Use Interaction on CB1 Receptor Density, Cannabis and Cannabinoid Research, 2, 1, 2017. Crossref

  104. Lazenka Matthew F., Kang Minho, De Dipanjana Datta, Selley Dana E., Sim-Selley Laura J., Δ9-Tetrahydrocannabinol Experience Influences ΔFosB and Downstream Gene Expression in Prefrontal Cortex, Cannabis and Cannabinoid Research, 2, 1, 2017. Crossref

  105. Meruelo A.D., Castro N., Cota C.I., Tapert S.F., Cannabis and alcohol use, and the developing brain, Behavioural Brain Research, 325, 2017. Crossref

  106. Llorente-Berzal Alvaro, Puighermanal Emma, Burokas Aurelijus, Ozaita Andrés, Maldonado Rafael, Marco Eva M., Viveros Maria-Paz, Abreu-Villaça Yael, Sex-Dependent Psychoneuroendocrine Effects of THC and MDMA in an Animal Model of Adolescent Drug Consumption, PLoS ONE, 8, 11, 2013. Crossref

  107. Perdikaris Panagiotis, Tsarouchi Martha, Fanarioti Eleni, Natsaridis Evangelos, Mitsacos Ada, Giompres Panagiotis, Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain, Neuropharmacology, 129, 2018. Crossref

  108. Ford Benjamin M., Franks Lirit N., Tai Sherrica, Fantegrossi William E., Stahl Edward L., Berquist Michael D., Cabanlong Christian V., Wilson Catheryn D., Penthala Narsimha R., Crooks Peter A., Prather Paul L., Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development, Pharmacological Research, 125, 2017. Crossref

  109. Viñals Xavier, Moreno Estefanía, Lanfumey Laurence, Cordomí Arnau, Pastor Antoni, de La Torre Rafael, Gasperini Paola, Navarro Gemma, Howell Lesley A., Pardo Leonardo, Lluís Carmen, Canela Enric I., McCormick Peter J., Maldonado Rafael, Robledo Patricia, Nestler Eric J., Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors, PLOS Biology, 13, 7, 2015. Crossref

  110. Richards John R., Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?, Medical Hypotheses, 103, 2017. Crossref

  111. Chang Linda, Chronicle Edward P., Functional Imaging Studies in Cannabis Users, The Neuroscientist, 13, 5, 2007. Crossref

  112. Cha Jae Myung, Case of cannabinoid hyperemesis syndrome with long-term follow-up, World Journal of Clinical Cases, 2, 12, 2014. Crossref

  113. Ladarre Delphine, Lenkei Zsolt, Cell-Autonomous Endocannabinoid Production Shapes Polarized and Dynamic Distribution and Signaling Patterns of Cannabinoid CB1 Receptors in Neurons, in Endocannabinoids and Lipid Mediators in Brain Functions, 2017. Crossref

  114. Enzi Björn, Lissek Silke, Edel Marc-Andreas, Tegenthoff Martin, Nicolas Volkmar, Scherbaum Norbert, Juckel Georg, Roser Patrik, Aleman André, Alterations of Monetary Reward and Punishment Processing in Chronic Cannabis Users: An fMRI Study, PLOS ONE, 10, 3, 2015. Crossref

  115. Solowij Nadia, Psychotomimetic and Cognitive Effects of Cannabis Use in the General Population, in The Complex Connection Between Cannabis and Schizophrenia, 2018. Crossref

  116. Reich CG, Mohammadi MH, Alger BE, Endocannabinoid modulation of fear responses: learning and state-dependent performance effects, Journal of Psychopharmacology, 22, 7, 2008. Crossref

  117. Cawich S.O., Deonarine U., Harding H.E., Dan D., Naraynsingh V., Cannabis and Postoperative Analgesia, in Handbook of Cannabis and Related Pathologies, 2017. Crossref

  118. De Caro Carmen, Leo Antonio, Citraro Rita, De Sarro Caterina, Russo Roberto, Calignano Antonio, Russo Emilio, The potential role of cannabinoids in epilepsy treatment, Expert Review of Neurotherapeutics, 17, 11, 2017. Crossref

  119. Walter Marc, Müller Christian A., Heinz Andreas, Neurobiologie, in Suchtmedizin, 2019. Crossref

  120. Farquhar Charlotte E., Breivogel Christopher S., Gamage Thomas F., Gay Elaine A., Thomas Brian F., Craft Rebecca M., Wiley Jenny L., Sex, THC, and hormones: Effects on density and sensitivity of CB1 cannabinoid receptors in rats, Drug and Alcohol Dependence, 194, 2019. Crossref

  121. D'Souza Deepak Cyril, Cortes-Briones Jose, Creatura Gina, Bluez Grai, Thurnauer Halle, Deaso Emma, Bielen Kim, Surti Toral, Radhakrishnan Rajiv, Gupta Aarti, Gupta Swapnil, Cahill John, Sherif Mohamed A, Makriyannis Alexandros, Morgan Peter T, Ranganathan Mohini, Skosnik Patrick D, Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial, The Lancet Psychiatry, 6, 1, 2019. Crossref

  122. Wiley Jenny L., Martin Billy R., Preclinical Pharmacological and Brain Bioassay Systems for CB1 Cannabinoid Receptors, in The Cannabinoid Receptors, 2009. Crossref

  123. Watanabe Masahito, Hayasaki Hana, Yurugi Yuko, Watanabe Katsuya, <b>Therapeutic potential of cannabidiol and its underlying mechanisms</b>, Journal of allied health sciences, 9, 2, 2018. Crossref

  124. Greene Nicholas Z., Wiley Jenny L., Yu Zhihao, Clowers Brian H., Craft Rebecca M., Cannabidiol modulation of antinociceptive tolerance to Δ9-tetrahydrocannabinol, Psychopharmacology, 235, 11, 2018. Crossref

  125. Trexler Kristen R., Nass Sara R., Crowe Molly S., Gross Joshua D., Jones Margaret S., McKitrick Austin W., Siderovski David P., Kinsey Steven G., Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice, Drug and Alcohol Dependence, 191, 2018. Crossref

  126. Zueva I., Vanaeva K. I., Shlyakhto E. V., The cognitive dysfunction in patients with obesity. Role of the endocannabinoids, "Arterial’naya Gipertenziya" ("Arterial Hypertension"), 18, 2, 2012. Crossref

  127. Mason Natasha L., Theunissen Eef L., Hutten Nadia R.P.W., Tse Desmond H.Y., Toennes Stefan W., Jansen Jacobus F.A., Stiers Peter, Ramaekers Johannes G., Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users, Addiction Biology, 26, 1, 2021. Crossref

  128. Prather Paul L., CB2 Cannabinoid Receptors: Molecular, Signaling, and Trafficking Properties, in Cannabinoids and the Brain, 2008. Crossref

  129. Perescis Martin F.J., Flipsen Nienke A.R., van Luijtelaar Gilles, van Rijn Clementina M., Altered SWD stopping mechanism in WAG/Rij rats subchronically treated with the cannabinoid agonist R(+)WIN55,212-2, Epilepsy & Behavior, 102, 2020. Crossref

  130. Wade Natasha E., Thomas Alicia M., Gruber Staci A., Tapert Susan F., Filbey Francesca M., Lisdahl Krista M., Binge and Cannabis Co-Use Episodes in Relation to White Matter Integrity in Emerging Adults, Cannabis and Cannabinoid Research, 5, 1, 2020. Crossref

  131. Smith Tricia H., Blume Lawrence C., Straiker Alex, Cox Jordan O., David Bethany G., McVoy Julie R. Secor, Sayers Katherine W., Poklis Justin L., Abdullah Rehab A., Egertová Michaela, Chen Ching-Kang, Mackie Ken, Elphick Maurice R., Howlett Allyn C., Selley Dana E., Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation, Molecular Pharmacology, 87, 4, 2015. Crossref

  132. Childers Steven R., Activation of G-Proteins in Brain by Endogenous and Exogenous Cannabinoids, in Drug Addiction, 2008. Crossref

  133. Pertwee Roger G., The Therapeutic Potential of Drugs that Target Cannabinoid Receptors or Modulate the Tissue Levels or Actions of Endocannabinoids, in Drug Addiction, 2008. Crossref

  134. Hwang Eun-Kyung, Lupica Carl R., Altered Corticolimbic Control of the Nucleus Accumbens by Long-term Δ9-Tetrahydrocannabinol Exposure, Biological Psychiatry, 87, 7, 2020. Crossref

  135. Kinsey Steven G., Wise Laura E., Ramesh Divya, Abdullah Rehab, Selley Dana E., Cravatt Benjamin F., Lichtman Aron H., Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects, Journal of Pharmacology and Experimental Therapeutics, 345, 3, 2013. Crossref

  136. McKinney Diana L., Cassidy Michael P., Collier Lauren M., Martin Billy R., Wiley Jenny L., Selley Dana E., Sim-Selley Laura J., Dose-Related Differences in the Regional Pattern of Cannabinoid Receptor Adaptation and in Vivo Tolerance Development to Δ9-Tetrahydrocannabinol, Journal of Pharmacology and Experimental Therapeutics, 324, 2, 2008. Crossref

  137. Kroon Emese, Kuhns Lauren, Hoch Eva, Cousijn Janna, Heavy cannabis use, dependence and the brain: a clinical perspective, Addiction, 115, 3, 2020. Crossref

  138. Liu Christopher W., Bhatia Anuj, Buzon-Tan Arlene, Walker Susan, Ilangomaran Dharini, Kara Jamal, Venkatraghavan Lakshmikumar, Prabhu Atul J., Weeding Out the Problem, Anesthesia & Analgesia, 129, 3, 2019. Crossref

  139. Celotto Laura, Eroli Francesca, Nistri Andrea, Vilotti Sandra, Long-term application of cannabinoids leads to dissociation between changes in cAMP and modulation of GABAA receptors of mouse trigeminal sensory neurons, Neurochemistry International, 126, 2019. Crossref

  140. Cossio Daniela, Stadler Henry, Michas Zoe, Johnston Colin, Lopez Hassan H., Disrupting the endocannabinoid system in early adolescence negatively impacts sociability, Pharmacology Biochemistry and Behavior, 188, 2020. Crossref

  141. Moreno Estefanía, Cavic Milena, Krivokuca Ana, Casadó Vicent, Canela Enric, The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?, Frontiers in Pharmacology, 10, 2019. Crossref

  142. Lichtman A. H., Martin B. R., Cannabinoid Tolerance and Dependence, in Cannabinoids, 168, 2005. Crossref

  143. Howlett A. C., Cannabinoid Receptor Signaling, in Cannabinoids, 168, 2005. Crossref

  144. Moore Nicole L. T., Greenleaf Ashley L. R., Acheson Shawn K., Wilson Wilkie A., Swartzwelder H. Scott, Kuhn Cynthia M., Role of Cannabinoid Receptor Type 1 Desensitization in Greater Tetrahydrocannabinol Impairment of Memory in Adolescent Rats, Journal of Pharmacology and Experimental Therapeutics, 335, 2, 2010. Crossref

  145. Yang Ying, Kreko‐Pierce Tabita, Howell Rebecca, Pugh Jason R., Long‐term depression of presynaptic cannabinoid receptor function at parallel fibre synapses, The Journal of Physiology, 597, 12, 2019. Crossref

  146. Sim-Selley Laura J., Schechter Nicole S., Rorrer W. Kirk, Dalton George D., Hernandez Jerry, Martin Billy R., Selley Dana E., Prolonged Recovery Rate of CB1 Receptor Adaptation after Cessation of Long-Term Cannabinoid Administration, Molecular Pharmacology, 70, 3, 2006. Crossref

  147. Urigüen Leyre, Esteban Susana, Callado Luís F., Álvaro-Bartolomé María, Meana J. Javier, García-Sevilla Jesús A., Chronic Effects of Cannabinoid Drugs on Monoaminergic Systems and the Role of Endocannabinoids and Cannabinoid Receptors in Human Brain Disorders, in Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders, 2013. Crossref

  148. DeVuono Marieka V., La Caprara Olivia, Sullivan Megan T., Bath Alexandra, Petrie Gavin N., Limebeer Cheryl L., Rock Erin M., Hill Matthew N., Parker Linda A., Role of the stress response and the endocannabinoid system in Δ9-tetrahydrocannabinol (THC)-induced nausea, Psychopharmacology, 237, 7, 2020. Crossref

  149. Panee Jun, Pomozi Viola, Franke Adrian A., Le Saux Olivier, Gerschenson Mariana, Chronic marijuana use moderates the correlations of serum cholesterol with systemic mitochondrial function and fluid cognition, Mitochondrion, 52, 2020. Crossref

  150. Parks Cory, Jones Byron C., Moore Bob M., Mulligan Megan K., Sex and Strain Variation in Initial Sensitivity and Rapid Tolerance to Δ9–Tetrahydrocannabinol, Cannabis and Cannabinoid Research, 5, 3, 2020. Crossref

  151. Coronado Clarisa, Wade Natasha E., Aguinaldo Laika D., Hernandez Mejia Margie, Jacobus Joanna, Neurocognitive Correlates of Adolescent Cannabis Use: an Overview of Neural Activation Patterns in Task-Based Functional MRI Studies, Journal of Pediatric Neuropsychology, 6, 1, 2020. Crossref

  152. DeVuono Marieka V., Parker Linda A., Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms, Cannabis and Cannabinoid Research, 5, 2, 2020. Crossref

  153. Ramaekers J.G., Mason N.L., Theunissen E.L., Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance, European Neuropsychopharmacology, 36, 2020. Crossref

  154. St. Pierre Michelle, Russo Ethan B., Walsh Zach, No Evidence of Altered Reactivity to Experimentally Induced Pain Among Regular Cannabis Users, The Clinical Journal of Pain, 36, 8, 2020. Crossref

  155. Bahji Anees, Stephenson Callum, Tyo Richard, Hawken Emily R., Seitz Dallas P., Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids, JAMA Network Open, 3, 4, 2020. Crossref

  156. Soriano Delia, Brusco Alicia, Caltana Laura, Further evidence of anxiety- and depression-like behavior for total genetic ablation of cannabinoid receptor type 1, Behavioural Brain Research, 400, 2021. Crossref

  157. Hu Lian, Oden Neal, Tai Betty, VanVeldhuisen Paul, Prevalence of obesity among U.S. population with substance dependence, Drug and Alcohol Dependence, 217, 2020. Crossref

  158. Soriano Delia, Vacotto Marina, Brusco Alicia, Caltana Laura, Neuronal and synaptic morphological alterations in the hippocampus of cannabinoid receptor type 1 knockout mice, Journal of Neuroscience Research, 98, 11, 2020. Crossref

  159. Springer Seth D., Spooner Rachel K., Schantell Mikki, Arif Yasra, Frenzel Michaela R., Eastman Jacob A., Wilson Tony W., Regular recreational Cannabis users exhibit altered neural oscillatory dynamics during attention reorientation, Psychological Medicine, 2021. Crossref

  160. Ritchay Megan M., Huggins Ashley A., Wallace Alexander L., Larson Christine L., Lisdahl Krista M., Resting state functional connectivity in the default mode network: Relationships between cannabis use, gender, and cognition in adolescents and young adults, NeuroImage: Clinical, 30, 2021. Crossref

  161. Hoffman Alexander F., Hwang Eun-Kyung, Lupica Carl R., Impairment of Synaptic Plasticity by Cannabis, Δ9-THC, and Synthetic Cannabinoids, Cold Spring Harbor Perspectives in Medicine, 11, 5, 2021. Crossref

  162. Kesner Andrew J., Lovinger David M., Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings, Journal of Neurochemistry, 157, 5, 2021. Crossref

  163. Reid Hannah M. O., Snowden Taylor M., Shkolnikov Irene, Breit Kristen R., Rodriguez Cristina, Thomas Jennifer D., Christie Brian R., Prenatal alcohol and cannabis exposure can have opposing and region‐specific effects on parvalbumin interneuron numbers in the hippocampus, Alcoholism: Clinical and Experimental Research, 45, 11, 2021. Crossref

  164. Jung Flora, Lee Yung, Manzoor Saba, Hong Dennis, Doumouras Aristithes G., Effects of Perioperative Cannabis Use on Bariatric Surgical Outcomes: a Systematic Review, Obesity Surgery, 31, 1, 2021. Crossref

  165. Rodríguez-Manzo Gabriela, González-Morales Estefanía, Garduño-Gutiérrez René, Endocannabinoids Released in the Ventral Tegmental Area During Copulation to Satiety Modulate Changes in Glutamate Receptors Associated With Synaptic Plasticity Processes, Frontiers in Synaptic Neuroscience, 13, 2021. Crossref

  166. Schnakenberg Martin Ashley M, Kim Dae-Jin, Newman Sharlene D, Cheng Hu, Hetrick William P, Mackie Ken, O’Donnell Brian F, Altered cerebellar-cortical resting-state functional connectivity in cannabis users, Journal of Psychopharmacology, 35, 7, 2021. Crossref

  167. Morris Gerwyn, Sominsky Luba, Walder Kenneth R., Berk Michael, Marx Wolfgang, Carvalho André F., Bortolasci Chiara C., Maes Michael, Puri Basant K., Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia, Molecular Neurobiology, 59, 6, 2022. Crossref

  168. Augustin Shana M., Lovinger David M., Synaptic changes induced by cannabinoid drugs and cannabis use disorder, Neurobiology of Disease, 167, 2022. Crossref

  169. Spindle Tory R., Kuwabara Hiroto, Eversole Alisha, Nandi Ayon, Vandrey Ryan, Antoine Denis G., Umbricht Annie, Guarda Angela S., Wong Dean F., Weerts Elise M., Brain imaging of cannabinoid type I (CB 1 ) receptors in women with cannabis use disorder and male and female healthy controls , Addiction Biology, 26, 6, 2021. Crossref

  170. Trazzi Stefania, Steger Martin, Mitrugno Valentina Maria, Bartesaghi Renata, Ciani Elisabetta, CB1 Cannabinoid Receptors Increase Neuronal Precursor Proliferation through AKT/Glycogen Synthase Kinase-3β/β-Catenin Signaling, Journal of Biological Chemistry, 285, 13, 2010. Crossref

  171. Hirvonen J, Goodwin R S, Li C-T, Terry G E, Zoghbi S S, Morse C, Pike V W, Volkow N D, Huestis M A, Innis R B, Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers, Molecular Psychiatry, 17, 6, 2012. Crossref

  172. Busquets-Garcia Arnau, Puighermanal Emma, Pastor Antoni, de la Torre Rafael, Maldonado Rafael, Ozaita Andrés, Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses, Biological Psychiatry, 70, 5, 2011. Crossref

  173. Filbey Francesca M., Aslan Sina, Calhoun Vince D., Spence Jeffrey S., Damaraju Eswar, Caprihan Arvind, Segall Judith, Long-term effects of marijuana use on the brain, Proceedings of the National Academy of Sciences, 111, 47, 2014. Crossref

  174. Russo Ethan B., Spooner Chris, May Len, Leslie Ryan, Whiteley Venetia L., Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation, Cannabis and Cannabinoid Research, 7, 3, 2022. Crossref

  175. F. Amil Adrián, Rubio Ballester Belén, Maier Martina, F.M.J. Verschure Paul, Chronic use of cannabis might impair sensory error processing in the cerebellum through endocannabinoid dysregulation, Addictive Behaviors, 131, 2022. Crossref

  176. Henderson-Redmond Angela N., Sepulveda Diana E., Ferguson Erin L., Kline Aaron M., Piscura Mary K., Morgan Daniel J., Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ9-THC), Psychopharmacology, 239, 5, 2022. Crossref

  177. Eggan Stephen M, Stoyak Samuel R, Verrico Christopher D, Lewis David A, Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder, Neuropsychopharmacology, 35, 10, 2010. Crossref

  178. Aloufi Noof, Namkung Yoon, Traboulsi Hussein, Wilson Emily T., Laporte Stephane A., Kaplan Barbara L.F., Ross Matthew K., Nair Parameswaran, Eidelman David H., Baglole Carolyn J., Standardized Cannabis Smoke Extract Induces Inflammation in Human Lung Fibroblasts, Frontiers in Pharmacology, 13, 2022. Crossref

  179. Ho Wilson, Kolla Nathan J., The endocannabinoid system in borderline personality disorder and antisocial personality disorder: A scoping review, Behavioral Sciences & the Law, 40, 2, 2022. Crossref

  180. Sharkey Keith A., Proposed mechanisms of cannabinoid hyperemesis syndrome—how can cannabinoid pathways both relieve and cause vomiting?, in Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis, 2022. Crossref

  181. Woyach Victoria, Sherman Katherine, Hillard Cecilia J., Hopp Francis A., Hogan Quinn H., Dean Caron, Fatty acid amide hydrolase activity in the dorsal periaqueductal gray attenuates neuropathic pain and associated dysautonomia, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 323, 5, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain